“For the nine months ended July 31, 2026, the net impact to the consolidated statements of operations to resolve outstanding claims was $272.0 million, consisting of $325.8 million accrued litigation liability, partially offset by $53.8 million of insurance re…”10-Q · Sep 9, 2026 ↗
The Cooper Companies, Inc.
COO
Market read
The Cooper Companies, Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 20 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 10 directly disclosed connections are confirming.
- COO's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if COO's group or a disclosed connection begins moving with it.
Research brief
The story so far
No new filing conclusion is available. 0 of 20 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 10 directly disclosed connections are confirming.
No thresholded supportive filing evidence is available yet.
No thresholded adverse filing evidence is available yet.
- COO's market-adjusted activity becomes unusual and at least one connected name confirms.
Company research
Understand the business, not just the ticker
Use the company’s filings to identify the few operating, demand, cost, capital and regulatory variables that determine its earnings power.
- Which operating variable is changing?
- Is that change durable, cyclical or one-off?
- What evidence would disprove the current interpretation?
- Latest annual revenue changed +5.1% year over year.
- Operating cash flow covered net income at 2.12x in the latest annual period.
- Operating margin changed -1.4 percentage points in the latest annual period.
- P/E is 99% below the available filing-peer median; determine whether growth and quality justify the difference.
- EV/sales is 16% above the available filing-peer median; determine whether growth and quality justify the difference.
Price as of Sep 11, 2026
53.89Reported annual revenue and per-share history. This is accounting history, not a forecast.
What management says matters
Persistent and emerging business drivers
“Cash provided by financing activities in fiscal 2024 was primarily attributable to funds received from the 2024 Revolving Credit Facility, partially offset by repayments to fully repay all borrowings outstanding under the 2020 Term Loan Facility and the 2020…”10-K · Dec 5, 2025 ↗
“Other Expense, Net ($ in millions) 2025 2024 Foreign exchange loss $ 8.0 $ 5.2 Other expense, net 8.4 3.9 $ 16.4 $ 9.1 Foreign exchange loss was primarily due to movements of U.S.”10-K · Dec 5, 2025 ↗
“As a result of these competitive forces, we believe there will continue to be pricing pressure in the future.”10-K · Dec 5, 2025 ↗
Valuation discipline
Descriptive valuation snapshot
Price/sales 2.6× · EV/sales 3.2×. Comparisons use only industry-matched filing peers.
Mechanical 2.0-year scenarios are available as editable assumptions, not consensus.
Price action
How the market is pricing the story
Jodie does not have enough daily observations to draw a useful short-term chart for this asset. The latest quoted price was checked 11 Sept, 15:55 GMT-4; this is a coverage limitation, not a flat-price conclusion.
Developments
No sourced recent-development timeline yet
Jodie has not returned a relevant primary source or news item for COO. This is an evidence-coverage gap, not a conclusion that nothing material happened.
Business and financial condition
Reported financial figures are not available yet
Jodie has not returned structured SEC XBRL fundamentals for this asset. This is a coverage limitation, not an assessment of the business or its financial health.
Filing analysis
No comparable filing assessment is available yet
Jodie has not yet found a suitable current-versus-prior filing comparison for COO. This does not mean the latest filing was neutral or immaterial.
Business ecosystem
The relationships behind COO
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
ABBVAbbVie Inc.competitorDec 5, 2025 ▾
“With Paragard, we compete with manufacturers of hormonal IUDs including Bayer and AbbVie, Long Acting Reversible Contraceptives including Organon, and other forms of birth control.”
ALCAlcon Inc.competitorDec 5, 2025 ▾
“CooperVision Competition CooperVision competes in the spherical, toric and multifocal lens categories of the contact lens worldwide market against Johnson & Johnson Vision Care, Inc., Alcon Inc., Bausch + Lomb as well as other smaller companies with limited p…”
Depended on by
FGF&G Annuities & Life, Inc.customerFeb 26, 2026 ▾
“Cooper also alleges that he is a F&G customer and brings similar common law tort claims and alleges claims as a purported third-party beneficiary of an alleged contract.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 8 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
COO is currently a Follower in the organic co-movement group Medical Devices. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
Context history
Theme membership history
No durable theme membership has been observed for this name yet.